Dual function of programmed cell death 10 (PDCD10) in drug resistance

Cagri Urfali-Mamatoglu1, Hasan Hüseyin Kazan1, Ufuk Gündüz1

  • 1Department of Biological Sciences, Middle East Technical University, Ankara, Turkey.

Insights

Programmed Cell Death 10 (PDCD10) plays a dual role in cancer drug resistance. Modulating PDCD10 levels can either increase or decrease resistance, offering a novel target for overcoming chemotherapy challenges.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Drug resistance is a significant hurdle in cancer chemotherapy, often involving altered apoptosis pathways.
  • Programmed Cell Death 10 (PDCD10) is implicated in cell survival and apoptosis, but its specific role in drug resistance remains unclear.

Purpose of the Study:

  • To investigate the role of PDCD10 in mediating resistance to anti-cancer agents across various cell lines.
  • To explore PDCD10 as a potential therapeutic target for reversing drug resistance in cancer.

Main Methods:

  • Analysis of PDCD10 expression in drug-resistant versus parental cancer cell lines (MCF7, HeLa).
  • Manipulation of PDCD10 levels using siRNA (down-regulation) and overexpression.
  • Assessment of apoptosis markers, including caspase 3/7 activity and related gene expression.

Main Results:

  • PDCD10 expression is cell- and drug-specific, showing down-regulation in doxorubicin/docetaxel-resistant MCF7 cells and up-regulation in doxorubicin-resistant HeLa cells.
  • Altering PDCD10 levels demonstrated a dual effect: down-regulation increased resistance in MCF7 cells, while it enhanced sensitivity in resistant HeLa cells. Overexpression showed converse effects.
  • Changes in PDCD10 expression correlated with altered caspase 3/7 activity and apoptosis-related gene expression.

Conclusions:

  • PDCD10 exhibits a novel dual role in cancer drug resistance, influencing sensitivity and resistance depending on the cellular context and drug.
  • Targeting PDCD10 presents a promising strategy for developing new therapies to overcome drug resistance in cancer treatment.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.2K
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
2
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
2
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K